Statistics
Publications
120
Citations
9.6K
H-Index
42
Active since
2002
Michael Dickinson is an author at Peter MacCallum Cancer Centre specializing in medicine, oncology, and cancer immunotherapy.
Publications per year
2002–2025
120
120
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text
Medicine, Hematology, Oncology +8
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Fowler, Michael Dickinson, Martin Dreyling et al. · Nature Medicine · 2021 · 527 citations · Full text
Medicine, Hematology, Oncology +12
1–5 of 120